PT - JOURNAL ARTICLE AU - B N A Crooks AU - S A Deshpande AU - C Hall AU - M P Ward Platt AU - D W A Milligan TI - Adverse neonatal effects of maternal labetalol treatment AID - 10.1136/fn.79.2.F150 DP - 1998 Sep 01 TA - Archives of Disease in Childhood - Fetal and Neonatal Edition PG - F150--F151 VI - 79 IP - 2 4099 - http://fn.bmj.com/content/79/2/F150.short 4100 - http://fn.bmj.com/content/79/2/F150.full SO - Arch Dis Child Fetal Neonatal Ed1998 Sep 01; 79 AB - Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.